Press release about investment in Episentec

Posted on June 3, 2013 by Episentum

Almi Invest/Innovationsbron, the new lead investor in Episentec, has distributed a press release about their investment.

Allan Asp, Investment Manager at Almi Invest, comments: “We are happy to get this opportunity to invest in Episentec. Episentec has a very strong technological edge, and we are convinced that their Label-Enhanced SPR technology will significantly extend the application landscape of optical biosensors. We also note that the development of biosensor technology historically has a strong tradition in Sweden.”

The link to the complete press release (in Swedish) is found here.

Episentec completes financing round

Posted on May 20, 2013 by Episentum

We are proud to announce the successful completion of a financing round with contributions from Almi Innovationsbron AB and a number of private investors, and also from the existing owners.

We will now step up the activities and change the focus of the operations. After two successful years of product development and application development together with selected pilot customers, the focus will now be on marketing and sales and on customer application support. In addition to our established product lines – Episentec reagents and EpiGrammer software – we will also be offering labelling & purification services and SPR method development services.

We are looking forward to many rewarding meetings with new – and old! – customers and the development of many new, exciting applications based on our proprietary Label-Enhanced SPR technology.

For further information please contact Anders Hanning, CEO anders.hanning@episentec.com .